Pathogenic Role of EPAC1 Signaling in Retinopathy of Prematurity
Pathogenic Role of EPAC1 Signaling in Retinopathy of Prematurity
批准号:
10177281
负责人:
Wenbo Zhang
金额:
$12.5万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-09-01 至 2021-08-31
关键词:
Administrative SupplementAlkaliesAwardBlindnessBlood VesselsChemical InjuryCicatrixCorneaCorneal NeovascularizationCyclic AMPDataDepositionDevelopmentEdemaExposure toFutureImpairmentInflammationLeadLimbus CorneaeLipidsMechlorethamineMediator of activation proteinModelingMustard GasOryctolagus cuniculusPathogenicityPlayResearchRetinopathy of PrematurityRoleSecond Messenger SystemsSignal TransductionTerrorismTherapeutic EffectVisionVisual AcuityWorkbasechemical accidentchemical threatdesignexperimental studyinhibitor/antagonistnovelprevent
中文摘要
摘要
角膜意外暴露于化学物质(例如碱烧伤)或在针对美国平民的恐怖袭击期间或
武装力量(例如硫磺芥末烧伤)通常会导致角膜新生血管,其特征是
新生血管从角膜缘侵入角膜。角膜新生血管是一种视觉-
可能导致脂肪沉积、水肿、持续性炎症和疤痕形成的威胁条件,导致
角膜透明度和视力的损害。目前,治疗角膜只有几种选择
新生血管和这些治疗方法都有很大的局限性。有很大的需要开发新的
防止化学威胁下角膜新生血管和视力丧失的策略和治疗。在这
行政补充申请,我们建议进行试验,以产生初步数据,以
确定Epac1是否也在化学损伤后的角膜新生血管中发挥作用。这项计划的可行性
建议的工作得到了父母奖研究进展产生的数据的有力支持,以及
根据我们的初步数据。基于这项工作的试点数据,未来我们将进一步评估和优化
ESI-09等新型EPAC抑制剂对兔角膜氮芥末模型的治疗作用
烧了吧。拟议的试点工作,以及这项工作之后的未来研究,预计将显著
促进开发治疗角膜新生血管和术后恢复视力的新对策
化学威胁。
英文摘要
ABSTRACT
Corneal exposure to chemicals by accident (e.g. alkali burn) or during a terrorist attack against U.S. civilians or
armed forces (e.g. sulfur mustard burn) often leads to corneal neovascularization that is characterized by the
invasion of new blood vessels into the cornea from the limbus. Corneal neovascularization is a vision-
threatening condition that may lead to lipid deposition, edema, persistent inflammation and scarring, resulting
in impairment of corneal transparency and visual acuity. Currently, there are only a few options to treat corneal
neovascularization and these treatments have significant limitations. There is a great need to develop new
strategies and therapies to prevent corneal neovascularization and vision loss against chemical threats. In this
application for Administrative Supplements, we propose to conduct experiments to generate preliminary data to
determine if Epac1 also plays a role in corneal neovascularization after chemical injury. The feasibility of the
work proposed is strongly supported by data generated from the research progress of the parental award and
by our preliminary data. Based on pilot data from this work, in the future, we will further evaluate and optimize
the therapeutic effects of ESI-09 and other novel Epac inhibitors in a rabbit model of corneal nitrogen mustard
burn. The proposed pilot work, together with future studies following this work, is expected to significantly
facilitate the development of novel countermeasures to treat corneal neovascularization and restore vision after
chemical threats.
期刊论文(12)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1167/iovs.64.11.17
发表时间:
2023-08-01
期刊:
Investigative ophthalmology & visual science
影响因子:
4.4
作者:
[]
通讯作者:
DOI:
10.1167/iovs.18-24427
发表时间:
2018-09-04
期刊:
Investigative ophthalmology & visual science
影响因子:
4.4
作者:
[Ha Y, Liu W, Liu H, Zhu S, Xia F, Gerson JE, Azhar NA, Tilton RG, Motamedi M, Kayed R, Zhang W]
通讯作者:
Zhang W
DOI:
10.1159/000493151
发表时间:
2018
期刊:
Journal of vascular research
影响因子:
1.7
作者:
[Liu H, Zhang W, Lilly B]
通讯作者:
Lilly B
Editorial: Neuronal Development and Degeneration.
社论:神经元发育和变性。
DOI:
10.3389/fgene.2019.01213
发表时间:
2019
期刊:
Frontiers in genetics
影响因子:
3.7
作者:
[Fort,PatriceE, Xu,Nan-Jie, Zhang,Wenbo]
通讯作者:
Zhang,Wenbo
DOI:
10.3390/cells12232685
发表时间:
2023-11-22
期刊:
CELLS
影响因子:
6
作者:
[Buscho, Seth E., Xia, Fan, Shi, Shuizhen, Lin, Jonathan L., Szczesny, Bartosz, Zhang, Wenbo, Motamedi, Massoud, Liu, Hua]
通讯作者:
Liu, Hua
共 7 条
Anti-Aging Molecule Sirt6 in Neuroprotection in Diabetic Retina
-
批准号:10568150
-
项目类别:
-
资助金额:$54.19万
-
财政年份:2023
-
负责人:Wenbo Zhang
-
依托单位:
Pathogenic Role of EPAC1 Signaling in Retinopathy of Prematurity
-
批准号:10087936
-
项目类别:
-
资助金额:$37.59万
-
财政年份:2017
-
负责人:Wenbo Zhang
-
依托单位:
Mechanisms of Retinal Neuronal Injury
-
批准号:9759925
-
项目类别:
-
资助金额:$39.5万
-
财政年份:2012
-
负责人:Wenbo Zhang
-
依托单位:
Mechanisms of Retinal Neuronal Injury
-
批准号:10206146
-
项目类别:
-
资助金额:$38.32万
-
财政年份:2012
-
负责人:Wenbo Zhang
-
依托单位:
Mechanisms of retinal neuronal injury
-
批准号:9126561
-
项目类别:
-
资助金额:$38.25万
-
财政年份:2012
-
负责人:Wenbo Zhang
-
依托单位:
Mechanisms of retinal neuronal injury
-
批准号:8348385
-
项目类别:
-
资助金额:$36.67万
-
财政年份:2012
-
负责人:Wenbo Zhang
-
依托单位:
Mechanisms of Retinal Neuronal Injury
-
批准号:10445188
-
项目类别:
-
资助金额:$7.95万
-
财政年份:2012
-
负责人:Wenbo Zhang
-
依托单位:
Mechanisms of retinal neuronal injury
-
批准号:8545859
-
项目类别:
-
资助金额:$36.34万
-
财政年份:2012
-
负责人:Wenbo Zhang
-
依托单位:
Mechanisms of retinal neuronal injury
-
批准号:8913190
-
项目类别:
-
资助金额:$37.49万
-
财政年份:2012
-
负责人:Wenbo Zhang
-
依托单位:
Mechanisms of retinal neuronal injury
-
批准号:8708877
-
项目类别:
-
资助金额:$37.49万
-
财政年份:2012
-
负责人:Wenbo Zhang
-
依托单位:
海外基金